Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

about

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry.

Item

http://www.wikidata.org/entity/Q55086137

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@en

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@nl

type

Item

label

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@en

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@nl

prefLabel

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@en

Delayed Treatment Acceleration ...... ata from the Corrona Registry.

@nl

P1476

Delayed Treatment Acceleration ...... Data from the Corrona Registry

@en

P2093

Connie Chen

http://www.w3.org/2001/XMLSchema#string

David Gruben

http://www.w3.org/2001/XMLSchema#string

Dimitrios A Pappas

http://www.w3.org/2001/XMLSchema#string

Heather J Litman

http://www.w3.org/2001/XMLSchema#string

Jamie Geier

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Bourret

http://www.w3.org/2001/XMLSchema#string

Joel M Kremer

http://www.w3.org/2001/XMLSchema#string

John S Andrews

http://www.w3.org/2001/XMLSchema#string

Robert A Gerber

http://www.w3.org/2001/XMLSchema#string

Winnie D Hua

http://www.w3.org/2001/XMLSchema#string

P2860

The Corrona US registry of rheumatic and autoimmune diseases

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.

Comparing Healthcare Costs Associated with Oral and Subcutaneous Methotrexate or Biologic Therapy for Rheumatoid Arthritis in the United States.

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.

Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

P304

148-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29910846

http://www.w3.org/2001/XMLSchema#string

P932

5973251

http://www.w3.org/2001/XMLSchema#string